Cardiac Medications and the Renin-Angiotensin-Aldosterone System

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This session reviews the management of the renin-angiotensin-aldosterone system (RAAS) in regard to myocardial infarction, heart failure and hypertension. The physiology and pharmacologic management of the RAAS is reviewed. Pharmacology, indications, contraindications, adverse reactions and nursing considerations are presented. Relevant clinical trials for each class of medications are reviewed to illustrate evidence-based utilization.

Objectives

Identify the role of the RAAS in the progression of cardiac disease.
Discuss the indications for medications affecting the RAAS.
Consider the nursing implications for each class of medications that modify the RAAS, including side effects and monitoring parameters.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for 1.00 contact hours.

Disclosure

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.

Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.